Lassman, A. B., Polley, M. C., Iwamoto, F. M., Sloan, A. E., Wang, T. J., Aldape, K. D., Wefel, J. S., Gondi, V., Gutierrez, A. N., Manasawala, M. H., Gilbert, M. R., Sulman, E. P., Wolchok, J. D., Green, R. M., Neil, E. C., Lukas, R. V., Goldlust, S. A., Snuderl, M., Galbraith, K., Dignam, J. J., Won, M., Mehta, M. P. (2025). Dual Immune Check Point Blockade in MGMT -Unmethylated Newly Diagnosed Glioblastoma: NRG Oncology BN007, a Randomized Phase II/III Clinical Trial. Journal of Clinical Oncology. https://doi.org/10.1200/jco-25-00618